Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 8/20 | 0.56 |
| ▸ | MME | P08473 | 1/20 | 0.56 |
| ▸ | CPA1 | P15085 | 1/20 | 0.56 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.56 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.54 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.54 |
| ▸ | NPY4R | P50391 | 4/20 | 0.53 |
| ▸ | NPY1R | P25929 | 3/20 | 0.53 |
| ▸ | NPY2R | P49146 | 3/20 | 0.53 |
| ▸ | NTSR2 | O95665 | 2/20 | 0.52 |
| ▸ | NTSR1 | P30989 | 2/20 | 0.52 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.51 |
| ▸ | CTSD | P07339 | 1/20 | 0.50 |
| ▸ | NPY5R | Q15761 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29521490 | 0.96 | CTSD (0.54) | ACEMMECPA1ACE2OPRM1 | |
| SCHEMBL29822653 | 0.92 | ACE (0.59) | ACEMMECPA1ACE2OPRM1 | |
| SCHEMBL30900774 | 0.92 | NTSR2 (0.53) | ACEMMECPA1ACE2OPRM1 | |
| SCHEMBL30900760 | 0.91 | ACE (0.61) | ACEMMECPA1ACE2NPY4R | |
| SCHEMBL30051238 | 0.91 | CTSD (0.58) | ACEMMECPA1ACE2OPRM1 | |
| SCHEMBL29713848 | 0.91 | ACE (0.58) | ACEMMECPA1ACE2OPRM1 | |
| SCHEMBL30638818 | 0.90 | ACE (0.55) | ACEMMECPA1ACE2OPRM1 | |
| SCHEMBL31318683 | 0.90 | ACE (0.57) | ACEMMECPA1ACE2OPRM1 | |
| SCHEMBL30538854 | 0.90 | OPRM1 (0.56) | ACEOPRM1OPRD1NPY4RNPY1R | |
| SCHEMBL30272520 | 0.89 | OPRD1 (0.58) | ACEMMECPA1ACE2OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250339504-A1 | CANCER VACCINE WITH USE OF COMMON CANCER ANTIGEN COCKTAIL, TCR/CAR-T CELL THERAPEUTIC, COMPANION DIAGNOSTIC METHOD, AND METHOD FOR DIAGNOSING RISK OF CANCER ONSET BY DETECTING CIRCULATING TUMOR CELLS | NATIONAL CANCER CENTER (JP) | 2025-11-06 | — | — | US | disclosed |